Progenity to Showcase New Data at Digestive Disease Week?

SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, this week announced three upcoming poster presentations. Alongside their women?s health products, Progenity has an extensive and innovative pipeline of ingestible molecular diagnostics and therapeutic products in development for gastrointestinal disorders, such as inflammatory bowel